Tags

Type your tag names separated by a space and hit enter

Significant Radiation Dose Reduction in the Hybrid Operating Room Using a Novel X-ray Imaging Technology.
Eur J Vasc Endovasc Surg. 2015 Oct; 50(4):480-6.EJ

Abstract

OBJECTIVE/BACKGROUND

To prospectively quantify radiation dose change in aortoiliac endovascular procedures in the hybrid operating room (OR) for patients and medical staff with a novel X-ray imaging technology (ClarityIQ technology), and to assess whether procedure or fluoroscopy time or dose of iodinated contrast was affected.

METHODS

A prospective study including 138 patients was performed to compare radiation dose before and after installation of a novel X-ray imaging technology. Endovascular aneurysm repair (EVAR) was performed in 37 patients and an endovascular procedure for aortoiliac occlusive disease (AIOD) in 101. Patient radiation dose in air kerma (AK) and dose area product (DAP), patient demographics, and procedural data were recorded. Staff radiation dose was measured with real time personal dosimetry measurements. In both the EVAR and AIOD groups the reference system, ALX (AlluraXper FD20; Philips Healthcare, Best, the Netherlands), was compared with the upgraded X-ray system, CIQ (AlluraClarity FD20; Philips Healthcare). Procedure time, fluoroscopy time, and iodinated contrast dose were recorded.

RESULTS

Patient radiation dose reduction in the EVAR group, in median AK, was 56% (ALX = 1,262.5 mGy; CIQ = 556.0 mGy [p < .01]); and in median DAP it was 57% (ALX = 224.4 Gycm(2) and CIQ = 95.8 Gycm(2) [p < .01]). Patient radiation dose reduction in the AIOD group, in median AK, was 76% (ALX = 1,011.0 mGy; CIQ = 248.0 mGy [p < .01]); and in median DAP it was 73% (ALX = 138.1 Gycm(2); CIQ = 38.0 Gycm(2) [p < .01]). Staff dose reduction in the EVAR group was 16% (ALX = 70.1 μSv; CIQ = 59.2 μSv [p = .43]) and in the AIOD group it was 69% (ALX = 96.2 μSv; CIQ = 30.1 μSv [p < .01]). There was no statistically significant difference between patient demographics, procedure time, fluoroscopy time, and iodinated contrast medium use in the two treatment groups before and after installation.

CONCLUSION

A novel X-ray imaging technology in the hybrid OR suite resulted in a significant reduction of patient and staff radiation dose without affecting procedure length, fluoroscopy time, or use of contrast.

Authors+Show Affiliations

Department of Surgery, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands. Electronic address: r.v.d.haak@jbz.nl.Medical Physics, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands.Philips Healthcare, Best, The Netherlands.Department of Surgery, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands.Department of Surgery, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

26286386

Citation

van den Haak, R F F., et al. "Significant Radiation Dose Reduction in the Hybrid Operating Room Using a Novel X-ray Imaging Technology." European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery, vol. 50, no. 4, 2015, pp. 480-6.
van den Haak RF, Hamans BC, Zuurmond K, et al. Significant Radiation Dose Reduction in the Hybrid Operating Room Using a Novel X-ray Imaging Technology. Eur J Vasc Endovasc Surg. 2015;50(4):480-6.
van den Haak, R. F., Hamans, B. C., Zuurmond, K., Verhoeven, B. A., & Koning, O. H. (2015). Significant Radiation Dose Reduction in the Hybrid Operating Room Using a Novel X-ray Imaging Technology. European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery, 50(4), 480-6. https://doi.org/10.1016/j.ejvs.2015.06.025
van den Haak RF, et al. Significant Radiation Dose Reduction in the Hybrid Operating Room Using a Novel X-ray Imaging Technology. Eur J Vasc Endovasc Surg. 2015;50(4):480-6. PubMed PMID: 26286386.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Significant Radiation Dose Reduction in the Hybrid Operating Room Using a Novel X-ray Imaging Technology. AU - van den Haak,R F F, AU - Hamans,B C, AU - Zuurmond,K, AU - Verhoeven,B A N, AU - Koning,O H J, Y1 - 2015/08/15/ PY - 2014/12/08/received PY - 2015/06/17/accepted PY - 2015/8/20/entrez PY - 2015/8/20/pubmed PY - 2015/12/15/medline KW - Aneurysm repair KW - Dosimetry KW - Endovascular KW - Radiation KW - Radiation exposure SP - 480 EP - 6 JF - European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery JO - Eur J Vasc Endovasc Surg VL - 50 IS - 4 N2 - OBJECTIVE/BACKGROUND: To prospectively quantify radiation dose change in aortoiliac endovascular procedures in the hybrid operating room (OR) for patients and medical staff with a novel X-ray imaging technology (ClarityIQ technology), and to assess whether procedure or fluoroscopy time or dose of iodinated contrast was affected. METHODS: A prospective study including 138 patients was performed to compare radiation dose before and after installation of a novel X-ray imaging technology. Endovascular aneurysm repair (EVAR) was performed in 37 patients and an endovascular procedure for aortoiliac occlusive disease (AIOD) in 101. Patient radiation dose in air kerma (AK) and dose area product (DAP), patient demographics, and procedural data were recorded. Staff radiation dose was measured with real time personal dosimetry measurements. In both the EVAR and AIOD groups the reference system, ALX (AlluraXper FD20; Philips Healthcare, Best, the Netherlands), was compared with the upgraded X-ray system, CIQ (AlluraClarity FD20; Philips Healthcare). Procedure time, fluoroscopy time, and iodinated contrast dose were recorded. RESULTS: Patient radiation dose reduction in the EVAR group, in median AK, was 56% (ALX = 1,262.5 mGy; CIQ = 556.0 mGy [p < .01]); and in median DAP it was 57% (ALX = 224.4 Gycm(2) and CIQ = 95.8 Gycm(2) [p < .01]). Patient radiation dose reduction in the AIOD group, in median AK, was 76% (ALX = 1,011.0 mGy; CIQ = 248.0 mGy [p < .01]); and in median DAP it was 73% (ALX = 138.1 Gycm(2); CIQ = 38.0 Gycm(2) [p < .01]). Staff dose reduction in the EVAR group was 16% (ALX = 70.1 μSv; CIQ = 59.2 μSv [p = .43]) and in the AIOD group it was 69% (ALX = 96.2 μSv; CIQ = 30.1 μSv [p < .01]). There was no statistically significant difference between patient demographics, procedure time, fluoroscopy time, and iodinated contrast medium use in the two treatment groups before and after installation. CONCLUSION: A novel X-ray imaging technology in the hybrid OR suite resulted in a significant reduction of patient and staff radiation dose without affecting procedure length, fluoroscopy time, or use of contrast. SN - 1532-2165 UR - https://www.unboundmedicine.com/medline/citation/26286386/Significant_Radiation_Dose_Reduction_in_the_Hybrid_Operating_Room_Using_a_Novel_X_ray_Imaging_Technology_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1078-5884(15)00402-5 DB - PRIME DP - Unbound Medicine ER -